期刊文献+

血清中CTnⅠ、GH和hs-CRP水平测定在儿科心血管疾病中的临床应用 被引量:1

Clinical application of cardiovascular disceases in paediatrics by determining serum CTn I,GH and hs-CRP levels
暂未订购
导出
摘要 目的探讨血清CTnⅠ、GH和hs-CRP水平测定在儿科心血管疾病中的临床应用。方法应用化学发光免疫法分析108例心肌炎患儿、56例青紫型心脏病患儿、36例GHD患儿和60例正常健康儿血清中的CTnⅠ水平,RIA测定血清中的GH和hs-CRP水平,并做了相关性分析。结果108例心肌炎患儿血清中的CTnⅠ、GH和hs-CRP分别为0.088±0.028ng/ml,15.63±2.16μg/L和1.35±0.14mmol/L,均较正常健康儿明显增高(P均<0.01);56例青紫型心脏病患儿血清中CTnⅠ为0.016±0.010ng/ml,较正常健康儿无明显差异(P>0.05),血清中GH和hs-CRP分别为10.89±3.14μg/L和1.22±0.13mmol/L,较正常健康儿明显增高(P均<0.01);36例GHD患儿血清中GH明显降低(P<0.05),而血脂分析表明:TC、LDL-C、apoB和TG明显高于正常健康儿(P分别<0.05或<0.01)。结论血清中CTnⅠ、GH和hs-CRP水平测定是诊断心肌炎、青紫型心脏病和GHD的较好方法,并具有观察治疗效果的作用。 Objective To study the clinical application of cardiovascular diseases in paediatrics by determining serum CTn I, GH and hs-CRP levels. Methods The CTn I was determined in serum with chemiluminescence and the GH and hs- CRP were determined in serum by RIA in 108 patients with myocarditis,56 patients with Qing-Zi style heart diseases,36 patients with GHD and 60 controls. Results Serum CTn I , GH and hs-CRP levels in the patients with myocarditis were significantly higher than those in controls (P〈0.01).Serum CTn I level in the patients with Qing-Zi style heart diseases was no different than those in controls(P〉0.05), but serum GH and hs-CRP levels were significantly higher(P〈0.01).Sernm GH levels in the patients with GHD was significantly lower than those in controls (P〈0.05),but serum TC,LDL-C,apoB and TG levels were significantly higher (P〈0.05or〈0.01). Conclusion Determining of serum CTn I ,GH and hs-CRP levels is a good markers in diagnosis and outcome prediction for cardiovascular diseases in paediatrics.
出处 《中国现代医药杂志》 2008年第12期12-14,共3页 Modern Medicine Journal of China
关键词 儿科学 血管疾病 CTnⅠ GH HS-CRP Paediatrics Cardiovascular disease CTn I GH hs-CRP
  • 相关文献

参考文献6

  • 1[2]Adamas JE,Bedor GS,Davila-poman VC,et al.Cardiac troponin Ⅰ:a marker with hish specificity for cardiac injury.Circulation,1993,88(1):101
  • 2[3]Giustina A,Lorusso R,Borghetti V,et al.Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy.Am Heart J,1996,131:620
  • 3[5]Jabs WJ,Logering BA,Gerke P,et al.Kidney as a second site of human C-reactive protein formation in vivo.Eur J Immunology,2003,33:152
  • 4[6]Braumwald E,Antman EM,Beasley JW,et al.ACC/AHA Guidelines for the management of patients with untable angina and nonstsegement elevation myocardial infarction a rapoet of American college of cardiology/American Heart Association task force or practice guideline.J Am coll cariol,2000,36(3):970
  • 5杨胜利,何秉贤.C-反应蛋白与冠心病[J].中华心血管病杂志,2001,29(3):187-188. 被引量:446
  • 6[8]Biasucci LM,Liu G,Grillo RL,et al.Elevated levels of Creactive protein in discharge in patients with unstable angina predict recurrent instability.Circulation,1999,99:855

二级参考文献3

  • 1US Departmentof Healthand Human Services Monograph,1996年,30页
  • 2Hatanaka K,Pathol Int,1995年,45卷,631页
  • 3Liuzzo G,New Engl J Med,1994年,331卷,417页

共引文献445

同被引文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部